We aimed to investigate restless leg syndrome (RLS) prevalence and sleep quality in patients with ankylosing spondylitis (AS) and to explore the association between RLS and measures of disease activity and physical function in AS. Methods: Twenty (5 female, 15 male) consecutive patients with AS and 20 (5 female, 15 male) healthy volunteers were enrolled in this study. RLS was diagnosed by International Restless Legs Syndrome Study Group (IRLSSG-2003). Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI), where scores >5 indicated poor sleep quality. Results: Prevalence of RLS was 55% (11 patients) in patients with AS. The mean RLS disability value was 21 (SD, 7.9). The modified Schober test levels were significantly higher (p=0.011) and Bath Ankylosing Spondylitis Functional Index (BASFI) scores were significantly lower (p=0.016) in the RLS group than in the non-RLS group. The Bath AS Disease Activity Index (BASDAI) scores were lower in the RLS group than in the non-RLS group, but the difference was not statistically significant (p=0.16). Sleep quality was poor in 12 patients [PSQI score=7.09 (SD, 3.67)]. Discussion and Conclusion: We emphasized that it is important to determine the existence of RLS and poor sleep quality in patients with AS. However, further examination by applying the diagnostic criteria for RLS and PSQI in more number of patients with AS will be useful.
A nkylosing Spondylitis (AS) is a chronic inflammatory rheumatic disease that primarily affects the spine and sacroiliac and peripheral joints. Its main symptoms include pain and stiffness [1, 2] .
Restless Legs Syndrome (RLS) is a chronic neurological condition associated with significant sleep disturbances and a resulting considerable negative impact on the patients' quality of life [3] . It is characterized by an irresistible urge to move, usually accompanied or caused by uncomfortable sensations in the legs [4] . These sensations generally occur while the patient is at rest and worsen in the evening or at night and can be temporarily relieved by movement [3, 5] . RLS is one of the leading causes of insomnia, affecting more than 5%-10% of the population [6] [7] [8] [9] . The incidence in women is twice than that in men [6, 9] . RLS is associated with a variety of conditions, including iron deficiency, uremic neuropathy, alcohol use, diabetes, amyloid, and barbiturate and phenothiazine therapies [3, [9] [10] [11] [12] . The pathophysiology of RLS remains unclear. However, pharmacological evidence indicates that the disorder is related to dopaminergic dysfunction in the central nervous system [3, 11] . scale for measuring the severity of RLS [International Restless Legs Scale (IRLS)] based on the questions proposed by its members who possessed clinical expertise regarding RLS [14] . Rheumatological diseases, including rheumatoid arthritis (RA), fibromyalgia (FM), and Sjögren syndrome, have also been reported to be associated with RLS symptoms in a large percentage of patients with these disorders [3, 7] . However, we could not find data on the prevalence of RLS symptoms in patients with AS.
Therefore, this study was carried out with the following aims:
1. To investigate the prevalence of RLS in patients with AS 2. To explore the associations between RLS and measures of disease activity and physical function in AS.
Materials and Methods
Twenty consecutive patients (15 male, 5 female) with AS defined according to the modified New York criteria 1984 were enrolled in the study [15] . Disease activity and functional status of patients were evaluated using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI), respectively [16, 17] . Pain and patient global assessments were determined with the visual analog scale (VAS; grades 0-10), Multi-Dimensional Health Assessment Questionnaire (MDHAQ; grades 0-10), and MDHAQ-Routine Assessment of Patient Index Data [MDHAQ-RAPID-3; including physical function (grades 0-10)], pain (0-10), and patient global estimate (0-10) (grades 0-30)] [18] .
The diagnosis of RLS was exclusively based on the four criteria and supportive clinical features proposed by IRLSSG-2003 [13] . The diagnosis was made by clinical evaluation and some questionnaires assessed by two neurologists.
IRLS was administrated to assess RLS severity [14] . Sleep disturbance was evaluated using the Pittsburgh Sleep Quality Index (PSQI) [19] .
Diagnostic criteria for RLS are shown in Table 1 . Objective measures of RLS severity were evaluated using IRLS, which consists of 10 items that are graded from 0 to 4; a total score is then generated and ranges from 0 to 40. The items used to calculate the total IRLS score can be grouped as follows: factors related to symptoms severity (IRLS symptoms subscale) and those related to the impact of IRLS on daily living or quality of life (IRLS symptoms impact subscale). Scores of 0-10 indicate mild RLS severity, 11-20 indicate moderate, 21-30 indicate severe, and 31-40 indicate very severe [14] .
PSQI is a self-reporting measure assessing sleep quality and disturbances in the previous month. It includes 19 items, generating seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each item is scored between 0 and 3 points according to the frequency of symptoms. A global score can range from 0 (no sleep difficulty) to 21 (severe sleep difficulty). A total score of ≥5 is considered suggestive of clinically poor sleep quality [19] . Excessive daytime sleepiness is the overwhelming urge to sleep during the day when one would rather be active. Epworth Sleepiness Scale (ESS) was used to assess excessive daytime sleepi- ness. It consists of 8 items, each graded from 0 to 3, and the total score can range from 0 to 24. A total score of ≥10 is indicative of excessive daytime sleepiness [20] . The degree of fatigue was evaluated using the Fatigue Severity Scale (FSS), which consists of 9 items, each graded from 0 to 7. The total score can range from 0 to 63, where scores ≥36 indicate a high degree of fatigue [21] .
The necessary approval by the local institutional review board was obtained for this scientific research.
Statistical Analysis
Statistical Package for Social Sciences (SPSS) for Windows 16.0 was used for statistical analysis. One sample t-test, independent t-test, and F-test were used for quantitative comparisons. The Pearson's chi-square and Fischer's exact tests were used for the comparison of categorical variables. The results were evaluated within 95% confidence interval, and p<0.05 was considered statistically significant. For continuous variables (assumed normal distribution), the Pearson's correlation coefficient was used. The Student's t-test was used to compare the mean values of electrophysiological tests between the patients and controls. The data were analyzed using SPSS II computer program, version 10. The data were expressed as mean±2SD.
Results
The demographic, clinical, and laboratory characteristics of patients with AS are shown in Table 2 . RLS was found in 11 patients with AS (55%) and in one healthy control (5%). The mean RLS disability value was 21 (SD, 7.91) in patients with AS. Among AS patients with RLS, two (18.1%) had very severe RLS (score, 31-40), three (27.2%) had severe RLS (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , five (45.4%) had moderate RLS (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , and one (9.0%) had mild RLS (1-10). The disease duration was longer in the non-RLS group, but it was not statistically significant (p=0.25). There was no significant correlation in terms of age, age at onset, and disease duration between the RLS and non-RLS groups. There were no significant differences in terms of ferritin levels between the RLS and non-RLS groups (p=0.86).
The mean PSQI was 7.09 (SD, 3.67; range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , and 80% of patients had poor sleep quality. Higher PSQI levels were associated with worse sleep quality. There were no significant differences for clinical scores between patients with poor sleep quality and those with better sleep quality (Table 3) . PSQI levels were higher in the RLS group than in the non-RLS group (8.4±3.6 and 7.3±4, respectively), but the difference was not statistically significant (p=0.547).
Sleep quality and fatigue scores were evaluated. The PSQI, ESS, and FSS scores of patients with RLS were 7.09±3.67, 8.35±6.28, and 42.30±14.70, respectively. The patients complained of worse sleep quality (80%), excessive daytime sleepiness (45%), and increased fatigue (80%) ( Table 4 ).
Fatigue scores were significantly higher (p=0.039) and daytime sleepiness was increased in patients with worse sleep quality ( Table 5 ).
The modified Schober test scores were significantly higher (p=0.011) and BASFI scores were significantly lower (p=0.016) in the RLS group than in the non-RLS group.
There was a positive correlation between modified Schober and IRLS scores (57.6%; p=0.008). BASDAI scores were low in the RLS group, but they were not statistically significant (p=0. 16) . No significant differences were found in other parameters between the RLS and non-RLS groups ( Table 6 ). There were no significant differences in ESR and CRP levels between the RLS and non-RLS groups.
Discussion
RLS prevalence in the general population is estimated to be 2.5%-10% [3, 7, 10] . In a study that examined RLS in patients with rheumatological conditions, 25% of patients with RA, 31% with FM, 24% with Sjögren syndrome, and 22% with scleroderma had RLS [3] . Salih et al. [10] found RLS in 25% of patients with RA, and most were female (83%). The prevalence of both RLS and rheumatological diseases increases with aging; therefore, these conditions may occur concomitantly. It is likely that many rheumatologists have encountered patients with RLS. In addition, RLS is often unrecognized, and rheumatological or painful disorders are suggested as the differential diagnosis, leading to referral to a rheumatologist [3] . The clinical criteria of the modified New York Classification for AS include low back pain and stiffness that improves with exercise but not relieved by rest [15] . In the absence of a structured interview, this symptomatology may be misinterpreted as the primary feature of RLS, which is the relief of sensory symptoms by movement. The risk here is the overestimation of RLS prevalence among patients with AS. In our study, this condition was taken into consideration while evaluating the patients.
In our study, RLS was found in 11 (55%) patients with AS.
The clinical severity of RLS was 21.0±7.91 (severe). The sleep quality was poorer (PSQI score=8.36±3.59) in the RLS group than in the non-RLS group.
Sleep dysfunction is very common in patients with RLS and is frequently attributed to their leg symptoms. It is noteworthy that approximately nine of every 10 patients with RLS reported at least one sleep-related symptom. RLS often has a profound impact on sleep and the quality of life [22] .
Da Costa et al. [23] used PSQI for evaluating the sleep quality in patients with spondyloarthropathy and found that 68.8% of patients were poor sleepers (global PSQI score >5). Addressing sleep problems in AS may have a synergistic effect on pain, functional status, and overall quality of life. In another study which examined sleep quality in patients with AS, the total amount of sleep was significantly lesser in patients with AS than in controls, mainly due to several periods of wakefulness during the night [24] . In patients with AS, pain was correlated with difficulty in sleep initiation and poor sleep quality, whereas stiffness was correlated with difficulty in waking and feeling tired and clumsy in the morning [25] .
We speculated that RLS was a result of inflammation and/ or autoimmunity in patients with AS, because there was no metabolic abnormality or low serum ferritin levels in these patients.
RLS was found in a less proportion of patients with permanent disability (patients with low scores in the modified Schober test and those with high scores in BASFI). Physical function was measured using BASFI and remained impaired owing to the structural damage to the spine [26] . We observed that symptoms, especially pain and stiffness, due to RLS could be prominently seen in patients with permanent disability. Therefore, the symptoms associated with RLS could not be enunciated by patients with AS.
The medication taken by patients with AS and by controls represents an issue. For instance, opiates and calcium channel ligands, such as pregabalin and gabapentin, could be administered for residual pain in AS when nonsteroidal anti-inflammatory drugs are contraindicated. These drug classes could mask RLS symptoms and introduce a confusion bias. This condition was taken into consideration while evaluating the patient and control groups in our study.
The present study had several limitations. The study was performed with a small patient group in which most patients were male. This problem can be evaluated by studies with more number of patients and with no gender differences. Furthermore, we did not evaluate FM, which is more frequent in women and is now considered to be the most common cause of generalized musculoskeletal pain in women aged 20-55 years [27] . It is frequently associated with other rheumatic diseases, such as RA and systemic lupus erythematosus (SLE) [28] . Additionally, it is known that a higher prevalence of RLS is observed in patients with FM [29] . However, there are few reports on the prevalence of FM in patients with AS. In a study, only female patients with AS were evaluated, and FM was found to be present in 50% of female patients with AS [30] . In our study, only a quarter of patients were female, and FM was not evaluated.
The pathophysiology of RLS is not clear; however, pharmacological evidence indicates that the disorder is related to dopaminergic dysfunction in the central nervous system. Certain dopamine antagonists exacerbate the symptoms of RLS, while dopamine agonists relieve them [3, 6, 9, 11] . We could not evaluate the response to dopaminergic treatment for RLS.
In conclusion, we found that RLS and poor sleep quality were highly rated in patients with AS. We also determined an opposite correlation between spinal damage and RLS. We emphasized that it is important to determine the existence of RLS and poor sleep quality in patients with AS. Therefore, further examination by applying the diagnostic criteria for RLS and PSQI in patients with AS will be useful. Further studies are needed to evaluate the presence of RLS in more number of patients with AS.
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